Tags:AerospaceDefenseDeviceEnergyGasIndustryITManufacturingMarketMedicalMedTechOilSalesSensorsTechnology
OpSens focuses on the measure of FFR and dPR in interventional cardiology, offering an advanced optical-based pressure guidewire (OptoWire) that aims at improving the clinical outcome of patients with coronary artery disease. OpSens is also involved in industrial activities. The Company develops, manufactures and installs fibre optic sensing solutions for critical applications, such as the monitoring of oil wells and other industrial applications. OpSens aims to become a key player in the FFR market with the OptoWire, a nitinol-based optical guidewire. The OptoWire provides intra-coronary blood pressure measurements with unique, patented technologies. Immune to the adverse effects related to blood contact, it allows easy and reliable connectivity that leads to reliable FFR measurements in extended conditions of usage. It is also designed to provide cardiologists with optimized performances to navigate coronary arteries and cross blockages with ease and safety. Based on industry sources, the FFR market represented more than US$300 M in sales in 2014. It is expected to reach US$1 B med-term. OpSens Solutions, a leading manufacturer of fiber optic sensors, presents its latest advances with its White-Light Polarization Interferometry (WLPI) technology and its SemiConductor Band Gap (SCBG) technology. With several new sensor models, OpSens Solutions provides high-accuracy, high-stability measurements, and high-resolution detection solutions to meet the needs of industries such as: • Downhole fiber optic pressure and temperature sensor for Oil and Gas • Temperature & pressure monitoring for Energy-related applications • Precise instrumentation for Defense and Aerospace • Customized OEM fiber optic sensor solutions Our technology can measure temperature, pressure, linear displacement, constraint, force and load. Our sensors perform in many harsh environments and at high temperatures. They are also insensitive to RF radiation, MRI, EMI, nuclear and microwave.
Location: Canada, Quebec, Quebec City
Member count: 51-200
Total raised: $19.95M
Founded date: 2006

Investors 2

Funding Rounds 2

DateSeriesAmountInvestorsDeal News
08.12.2016-$14.95M-lumiravent...
17.05.2016-$5MLumira Ven...lumiravent...

Mentions in press and media 14

DateTitleDescriptionCategoryAuthorSource
13.01.2022OpSens Ann...Conference call on the results...--marketscre...
23.11.2021OpSens Ann...Conference call on the results...--marketscre...
08.11.2021OPSENS' SA...QUEBEC CITY, Nov. 8, 2021 /CNW...--marketscre...
13.10.2021OpSens Suc...QUEBEC, Quebec, October 13, 20...--lumiravent...
13.07.2021OpSens : A...Conference call on the results...--marketscre...
14.01.2020Opsens Rec...QUEBEC CITY /CNW Telbec/ – Ops...--lumiravent...
08.11.2019First Clin...QUEBEC CITY, QUEBEC – Opsens I...--lumiravent...
11.07.2019Opsens Rel...QUEBEC CITY, July 11, 2019 /CN...--lumiravent...
30.04.2019Opsens Sig...QUEBEC CITY, April 30, 2019 /C...--lumiravent...
11.04.2019Opsens Q2 ...QUEBEC CITY, April 11, 2019 /C...--lumiravent...
Show more